|
J Biol Chem, Vol. 274, Issue 25, 17777-17788, June 18, 1999
Molecular Cloning, Enzymatic Characterization, Developmental
Expression, and Cellular Localization of a Mouse Cytochrome P450
Highly Expressed in Kidney
Jixiang
Ma ,
Wei
Qu ,
Paula E.
Scarborough ,
Kenneth B.
Tomer§,
Cindy R.
Moomaw¶,
Robert
Maronpot¶,
Linda S.
Davis ,
Matthew D.
Breyer , and
Darryl C.
Zeldin
From the Laboratories of Pulmonary
Pathobiology, § Structural Biology, and
¶ Experimental Pathology, NIEHS, National Institutes of
Health, Research Triangle Park, North Carolina 27709 and the
Department of Medicine, Vanderbilt University,
Nashville, Tennessee 37232
A cDNA encoding a new cytochrome P450 was
isolated from a mouse liver library. Sequence analysis reveals that
this 1,886-base pair cDNA encodes a 501-amino acid polypeptide that
is 69-74% identical to CYP2J subfamily P450s and is designated
CYP2J5. Recombinant CYP2J5 was co-expressed with NADPH-cytochrome P450
oxidoreductase in Sf9 cells using a baculovirus system.
Microsomal fractions of CYP2J5/NADPH-cytochrome P450
oxidoreductase-transfected cells metabolize arachidonic acid to 14,15-, 11,12-, and 8,9-epoxyeicosatrienoic acids and 11- and
15-hydroxyeicosatetraenoic acids (catalytic turnover, 4.5 nmol of
product/nmol of cytochrome P450/min at 37 °C); thus CYP2J5 is
enzymologically distinct. Northern analysis reveals that CYP2J5
transcripts are most abundant in mouse kidney and present at lower
levels in liver. Immunoblotting using a polyclonal antibody against a
CYP2J5-specific peptide detects a protein with the same electrophoretic
mobility as recombinant CYP2J5 most abundantly in mouse kidney
microsomes. CYP2J5 is regulated during development in a tissue-specific
fashion. In the kidney, CYP2J5 is present before birth and reaches
maximal levels at 2-4 weeks of age. In the liver, CYP2J5 is absent
prenatally and during the early postnatal period, first appears at 1 week, and then remains relatively constant. Immunohistochemical
staining of kidney sections with anti-human CYP2J2 IgG reveals that
CYP2J protein(s) are present primarily in the proximal tubules and
collecting ducts, sites where the epoxyeicosatrienoic acids are known
to modulate fluid/electrolyte transport and mediate hormonal action.
In situ hybridization confirms abundant CYP2J5 mRNA
within tubules of the renal cortex and outer medulla.
Epoxyeicosatrienoic acids are endogenous constituents of mouse kidney
thus providing direct evidence for the in vivo metabolism
of arachidonic acid by the mouse renal epoxygenase(s). Based on these
data, we conclude that CYP2J5 is an enzymologically distinct,
developmentally regulated, protein that is localized to specific
nephron segments and contributes to the oxidation of endogenous renal
arachidonic acid pools. In light of the well documented effects of
epoxyeicosatrienoic acids in modulating renal tubular transport
processes, we postulate that CYP2J5 products play important functional
roles in the kidney.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Sun, W. Liu, D.-H. Lin, P. Yue, R. Kemp, L. M. Satlin, and W.-H. Wang
Epoxyeicosatrienoic Acid Activates BK Channels in the Cortical Collecting Duct
J. Am. Soc. Nephrol.,
March 1, 2009;
20(3):
513 - 523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Athirakul, J. A. Bradbury, J. P. Graves, L. M. DeGraff, J. Ma, Y. Zhao, J. F. Couse, R. Quigley, D. R. Harder, X. Zhao, et al.
Increased blood pressure in mice lacking cytochrome P450 2J5
FASEB J,
December 1, 2008;
22(12):
4096 - 4108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Terashvili, L. F. Tseng, H.-e. Wu, J. Narayanan, L. M. Hart, J. R. Falck, P. F. Pratt, and D. R. Harder
Antinociception Produced by 14,15-Epoxyeicosatrienoic Acid Is Mediated by the Activation of {beta}-Endorphin and Met-Enkephalin in the Rat Ventrolateral Periaqueductal Gray
J. Pharmacol. Exp. Ther.,
August 1, 2008;
326(2):
614 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Nusing, H. Schweer, I. Fleming, D. C. Zeldin, and M. Wegmann
Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity
Am J Physiol Renal Physiol,
July 1, 2007;
293(1):
F288 - F298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Liclican, J. C. McGiff, P. L. Pedraza, N. R. Ferreri, J. R. Falck, and M. A. Carroll
Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids
Am J Physiol Renal Physiol,
August 1, 2005;
289(2):
F386 - F392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhou, H.-H. Chang, J. Du, C.-Y. Wang, Z. Dong, and M.-H. Wang
Renal epoxyeicosatrienoic acid synthesis during pregnancy
Am J Physiol Renal Physiol,
January 1, 2005;
288(1):
F221 - F226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. DeLozier, C.-C. Tsao, S. J. Coulter, J. Foley, J. A. Bradbury, D. C. Zeldin, and J. A. Goldstein
CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
J. Pharmacol. Exp. Ther.,
September 1, 2004;
310(3):
845 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, Y. Zhao, J. A. Bradbury, J. P. Graves, J. Foley, J. A. Blaisdell, J. A. Goldstein, and D. C. Zeldin
Cloning, Expression, and Characterization of Three New Mouse Cytochrome P450 Enzymes and Partial Characterization of Their Fatty Acid Oxidation Activities
Mol. Pharmacol.,
May 1, 2004;
65(5):
1148 - 1158.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Ma, J. Graves, J. A. Bradbury, Y. Zhao, D. L. Swope, L. King, W. Qu, J. Clark, P. Myers, V. Walker, et al.
Regulation of Mouse Renal CYP2J5 Expression by Sex Hormones
Mol. Pharmacol.,
March 1, 2004;
65(3):
730 - 743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yaghi, J. A. Bradbury, D. C. Zeldin, S. Mehta, J. R. Bend, and D. G. McCormack
Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia
Am J Physiol Lung Cell Mol Physiol,
November 1, 2003;
285(5):
L1099 - L1105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhao, D. M. Pollock, D. C. Zeldin, and J. D. Imig
Salt-Sensitive Hypertension After Exposure to Angiotensin Is Associated With Inability to Upregulate Renal Epoxygenases
Hypertension,
October 1, 2003;
42(4):
775 - 780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miyazono, D. Zhu, R. Nemenoff, E. R. Jacobs, and E. P. Carter
Increased Epoxyeicosatrienoic Acid Formation in the Rat Kidney during Liver Cirrhosis
J. Am. Soc. Nephrol.,
July 1, 2003;
14(7):
1766 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. He, T. Podymow, J. Zimpelmann, and K. D. Burns
NO inhibits Na+-K+-2Cl- cotransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1)
Am J Physiol Renal Physiol,
June 1, 2003;
284(6):
F1235 - F1244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhao, D. M. Pollock, E. W. Inscho, D. C. Zeldin, and J. D. Imig
Decreased Renal Cytochrome P450 2C Enzymes and Impaired Vasodilation Are Associated With Angiotensin Salt-Sensitive Hypertension
Hypertension,
March 1, 2003;
41(3):
709 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. King, J. Ma, S. Srettabunjong, J. Graves, J. A. Bradbury, L. Li, M. Spiecker, J. K. Liao, H. Mohrenweiser, and D. C. Zeldin
Cloning of CYP2J2 Gene and Identification of Functional Polymorphisms
Mol. Pharmacol.,
April 1, 2002;
61(4):
840 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev,
January 1, 2002;
82(1):
131 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Tsao, S. J. Coulter, A. Chien, G. Luo, N. P. Clayton, R. Maronpot, J. A. Goldstein, and D. C. Zeldin
Identification and Localization of Five CYP2Cs in Murine Extrahepatic Tissues and Their Metabolism of Arachidonic Acid to Regio- and Stereoselective Products
J. Pharmacol. Exp. Ther.,
October 1, 2001;
299(1):
39 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Imig
Eicosanoid regulation of the renal vasculature
Am J Physiol Renal Physiol,
December 1, 2000;
279(6):
F965 - F981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Xie, Q.-Y. Zhang, Y. Zhang, T. Su, J. Gu, L. S. Kaminsky, and X. Ding
Induction of Mouse CYP2J by Pyrazole in the Eye, Kidney, Liver, Lung, Olfactory Mucosa, and Small Intestine, but Not in the Heart
Drug Metab. Dispos.,
November 1, 2000;
28(11):
1311 - 1316.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C.-C. Tsao, J. Foley, S. J. Coulter, R. Maronpot, D. C. Zeldin, and J. A. Goldstein
CYP2C40, a Unique Arachidonic Acid 16-Hydroxylase, Is the Major CYP2C in Murine Intestinal Tract
Mol. Pharmacol.,
August 1, 2000;
58(2):
279 - 287.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Z. Yu, L. M. Huse, P. Adler, L. Graham, J. Ma, D. C. Zeldin, and D. L. Kroetz
Increased CYP2J Expression and Epoxyeicosatrienoic Acid Formation in Spontaneously Hypertensive Rat Kidney
Mol. Pharmacol.,
May 1, 2000;
57(5):
1011 - 1020.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Qu, J. A. Bradbury, C.-C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker, L. S. Davis, M. D. Breyer, M. P. Waalkes, J. R. Falck, et al.
Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid omega -1 Hydroxylase Predominantly Expressed in Brain
J. Biol. Chem.,
June 29, 2001;
276(27):
25467 - 25479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Zeldin
Epoxygenase Pathways of Arachidonic Acid Metabolism
J. Biol. Chem.,
September 21, 2001;
276(39):
36059 - 36062.
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|